Evidences for pharmacokinetic interaction of riluzole and topiramate with pilocarpine in pilocarpine-induced seizures in rats

Epilepsy Research

Volumn 88, Issue 2-3, 2010, Pages 269-274

  Zgrajka, Wojciech ^a   Nieoczym, Dorota ^b   Czuczwar, Mirosław ^c   Kiś, Jacek ^c   Brzana, Wojciech ^a   Wlaź, Piotr ^b   Turski, Waldemar A ^a,c  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Animal model; Anticonvulsant drug; Epilepsy; Pilocarpine induced seizures; Riluzole; Topiramate

Indexed keywords

PILOCARPINE; RILUZOLE; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN LEVEL; CONVULSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; EPILEPTIC STATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONVULSANTS; DRUG INTERACTIONS; FRUCTOSE; MALE; PILOCARPINE; RATS; RATS, WISTAR; RILUZOLE; SEIZURES; STATUS EPILEPTICUS;

EID: 75849116354     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.11.010     Document Type: Article

References (29)

1. Anderson R.A., and Cowle J.B. Influence of pH on the effect of pilocarpine on aqueous dynamics. Br. J. Ophthalmol. 52 (1968) 607-611
2. Ben-Menachem E., Sander J.W., Stefan H., Schwalen S., and Schauble B. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy. Clin. Ther. 30 (2008) 1180-1195
3. Caldwell G.W., Wu W.N., Masucci J.A., McKown L.A., Gauthier D., Jones W.J., Leo G.C., and Maryanoff B.E. Metabolism and excretion of the antiepileptic/antimigraine drug, topiramate in animals and humans. Eur. J. Drug Metab. Pharmacokinet. 30 (2005) 151-164
4. Cavalheiro E.A., Fernandes M.J., Turski L., and Naffah-Mazzacoratti M.G. Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 35 (1994) 1-11
5. Cavalheiro E.A., Leite J.P., Bortolotto Z.A., Turski W.A., Ikonomidou C., and Turski L. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32 (1991) 778-782
6. Czapinski P., Blaszczyk B., and Czuczwar S.J. Mechanisms of action of antiepileptic drugs. Curr. Top. Med. Chem. 5 (2005) 3-14
7. De S.G., Scozzafava A., and Supuran C.T. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?. Chem. Biol. Drug Des. 74 (2009) 317-321
8. Ellis P.P., Littlejohn K., and Deitrich R.A. Enzymatic hydrolysis of pilocarpine. Invest. Ophthalmol. 11 (1972) 747-751
9. Endo T., Ban M., Hirata K., Yamamoto A., Hara Y., and Momose Y. Involvement of CYP2A6 in the formation of a novel metabolite, 3-hydroxypilocarpine, from pilocarpine in human liver microsomes. Drug Metab. Dispos. 35 (2007) 476-483
10. Ferrari A., Sternieri E., Ferraris E., and Bertolini A. Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis. Pharmacol. Res. 48 (2003) 1-9
11. Jette N., Hemming K., Hutton J.L., and Marson A.G. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database. Syst. Rev. (2008) CD001417
12. Kim J.E., Kim D.S., Kwak S.E., Choi H.C., Song H.K., Choi S.Y., Kwon O.S., Kim Y.I., and Kang T.C. Anti-glutamatergic effect of riluzole: comparison with valproic acid. Neuroscience 147 (2007) 136-145
13. Kudin A.P., bska-Vielhaber G., Vielhaber S., Elger C.E., and Kunz W.S. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45 (2004) 1478-1487
14. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96 (1949) 99-113
15. Ma L., Huang Y.G., Deng Y.C., Tian J.Y., Rao Z.R., Che H.L., Zhang H.F., and Zhao G. Topiramate reduced sweat secretion and aquaporin-5 expression in sweat glands of mice. Life Sci. 80 (2007) 2461-2468
16. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. (1998), Academic Press, Sydney
17. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
18. Rigoulot M.A., Koning E., Ferrandon A., and Nehlig A. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy. J. Pharmacol. Exp. Ther. 308 (2004) 787-795
19. Sanderink G.J., Bournique B., Stevens J., Petry M., and Martinet M. Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. J. Pharmacol. Exp. Ther. 282 (1997) 1465-1472
20. Shank R.P., and Maryanoff B.E. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate. CNS Neurosci. Ther. 14 (2008) 120-142
21. Silberstein S., Diener H.C., Lipton R., Goadsby P., Dodick D., Bussone G., Freitag F., Schwalen S., Ascher S., Morein J., Greenberg S., Biondi D., and Hulihan J. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache 48 (2008) 1087-1095
22. Turski L., Cavalheiro E.A., Sieklucka-Dziuba M., Ikonomidou-Turski C., Czuczwar S.J., and Turski W.A. Seizures produced by pilocarpine: neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain. Brain Res. 398 (1986) 37-48
23. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., and Cavalheiro E.A. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3 (1989) 154-171
24. Turski W.A., Cavalheiro E.A., Bortolotto Z.A., Mello L.M., Schwarz M., and Turski L. Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res. 321 (1984) 237-253
25. Turski W.A., Cavalheiro E.A., Coimbra C., da Penha B.M., Ikonomidou-Turski C., and Turski L. Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Res. 434 (1987) 281-305
26. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., and Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 9 (1983) 315-335
27. van Kan H.J., Groeneveld G.J., Kalmijn S., Spieksma M., van den Berg L.H., and Guchelaar H.J. Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis. Br. J. Clin. Pharmacol. 59 (2005) 310-313
28. Young D.S., and Bernes E.W. Specimen collection and processing: sources of biological variation. In: Tietz N.W. (Ed). Textbook of Clinical Chemistry (1986), W.B. Saunders, Philadelphia 478-518
29. Zarate C.A., and Manji H.K. Riluzole in psychiatry: a systematic review of the literature. Expert Opin. Drug Metab. Toxicol. 4 (2008) 1223-1234